NorthWest Biotherapeutics Inc (NWBO)

[dennisdave]

incredibly difficult to understand why NWBO never was granted FDA Orphan Drug Designation.
Still, it will be many years before they can present their Phase 3 readout

Additionally, 13 out of 16 patients remain alive today with the vast majority of patients still progression free.

Having said that if Diakonos can keep this rate of OS in their future P3 going then DCVAXL is obsolete the moment Diakonos receives approval.